human immunodeficiency virus (hiv)
Showing 1 - 25 of 61
Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) Trial in New York (Video Format, Health Educator)
Not yet recruiting
- Human Immunodeficiency Virus (HIV)
- Hepatitis C (HCV)
- Video Format
- Health Educator
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 21, 2023
Chlamydia Infections, Gonorrhea, Syphilis Infection Trial in Spain (Participatory teaching group, Sham control group)
Not yet recruiting
- Chlamydia Infections
- +5 more
- Participatory teaching group
- Sham control group
-
Sant Andreu de la Barca, Barcelona, Spain
- +3 more
Feb 3, 2023
Human Immunodeficiency Virus (HIV) Trial in Flagstaff (e-HERO: Ending the HIV Epidemic in Rural Oklahoma)
Recruiting
- Human Immunodeficiency Virus (HIV)
- e-HERO: Ending the HIV Epidemic in Rural Oklahoma
-
Flagstaff, ArizonaNorthern Arizona University
Dec 16, 2022
Opioid-Related Disorders, Hepatitis C (HCV), Human Immunodeficiency Virus (HIV) Trial (Harm reduction kiosk)
Not yet recruiting
- Opioid-Related Disorders
- +7 more
- Harm reduction kiosk
- (no location specified)
Dec 9, 2022
Human Immunodeficiency Virus (HIV) Trial in Puerto Rico, United States (ABBV-382, Placebo for ABBV-382)
Recruiting
- Human Immunodeficiency Virus (HIV)
- ABBV-382
- Placebo for ABBV-382
-
Bakersfield, California
- +20 more
Dec 15, 2022
Human Immunodeficiency Virus (HIV) Trial in Puerto Rico, United States (Budigalimab, Placebo)
Completed
- Human Immunodeficiency Virus (HIV)
- Budigalimab
- Placebo
-
Bakersfield, California
- +9 more
Oct 14, 2022
Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)
Active, not recruiting
- Human Immunodeficiency Virus (HIV)
- Doravirine, Tenofovir, Lamivudine
- +2 more
- (no location specified)
Sep 1, 2022
Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)
Recruiting
- Human Immunodeficiency Virus (HIV)
- DRV/COBI FDC
-
Atlanta, Georgia
- +5 more
Aug 2, 2022
Human Immunodeficiency Virus (HIV), AIDS Virus Trial in Silver Spring (A244, B.63521, 50µg ALFQ)
Not yet recruiting
- Human Immunodeficiency Virus (HIV)
- AIDS Virus
- A244
- +4 more
-
Silver Spring, MarylandWalter Reed Army Institute of Research, Clinical Trials Center
Jul 20, 2022
Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
Recruiting
- Human Immunodeficiency Virus (HIV)
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Jun 13, 2022
Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)
Completed
- Human Immunodeficiency Virus (HIV)
- Ixazomib 1 MG
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 8, 2021
Human Immunodeficiency Virus (HIV) Trial in Gainesville (Skyn Monitor Lab Session 1, Skyn Monitor Field Test with EMA App, Skyn
Recruiting
- Human Immunodeficiency Virus (HIV)
- Skyn Monitor Lab Session 1
- +2 more
-
Gainesville, Florida
- +1 more
Aug 16, 2021
Human Immunodeficiency Virus Prevention, Human Immunodeficiency Virus (HIV) Trial run by the NIAID (VRC-HIVRGP096-00-VP, Alum
Completed
- Human Immunodeficiency Virus Prevention
- Human Immunodeficiency Virus (HIV)
- VRC-HIVRGP096-00-VP
- Alum Adjuvant
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2021
Condomless Sex, Human Immunodeficiency Virus (HIV), Sexually Transmitted Infection (STI) Trial in United States (Face-to-Face
Terminated
- Condomless Sex
- +3 more
- Face-to-Face Young Women's CoOp (YWC)
- +2 more
-
Durham, North Carolina
- +3 more
Mar 21, 2021
Human Immunodeficiency Virus (HIV) Trial in United States (SB-728mR-T, Cyclophosphamide)
Completed
- Human Immunodeficiency Virus (HIV)
- SB-728mR-T
- Cyclophosphamide
-
San Francisco, California
- +4 more
Mar 17, 2021
Human Immunodeficiency Virus (HIV) Trial in Hanoi (Enhanced Treatment Support (ETS))
Unknown status
- Human Immunodeficiency Virus (HIV)
- Enhanced Treatment Support (ETS)
-
Hanoi, VietnamHanoi Medical University
Feb 17, 2021
Human Immunodeficiency Virus (HIV) Trial in New York, Aarhus, Cologne (3BNC117, Romidepsin)
Completed
- Human Immunodeficiency Virus (HIV)
-
New York, New York
- +2 more
Feb 3, 2021
Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and
Completed
- Human Immunodeficiency Virus (HIV)
- D/C/F/TAF Fixed-Dose Combination (FDC)
-
Bergamo, Italy
- +17 more
Nov 24, 2020
Human Immunodeficiency Virus (HIV) Trial in Denpasar (HIV self-testing among female sex workers)
Recruiting
- Human Immunodeficiency Virus (HIV)
- HIV self-testing among female sex workers
-
Denpasar, Bali, IndonesiaKerti Praja Foundation
Oct 2, 2020
Human Immunodeficiency Virus (HIV), Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH) Trial in
Completed
- Human Immunodeficiency Virus (HIV)
- +2 more
- tesamorelin
- Placebo
-
Bethesda, Maryland
- +1 more
Jan 13, 2020
Pericardial Fat and Inflammation in HIV Patients and Controls
Completed
- Coronary Artery Disease
- Human Immunodeficiency Virus (HIV)
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jan 15, 2020
Condomless Sex, Human Immunodeficiency Virus (HIV), Sexually Transmitted Infections (STIs) Trial in Cape Town (Young Women's
Completed
- Condomless Sex
- +6 more
- Young Women's Health CoOp (YWHC)
- Standard HTC
-
Cape Town, South AfricaThe South African Medical Research Council (SAMRC),
Jan 9, 2020
New Strategies to Assess Anal Cancer Risk In Women
Completed
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
- Perianal and Digital Anorectal Exam
- +3 more
-
Atlanta, GeorgiaThe Ponce Center
Nov 4, 2019
Human Immunodeficiency Virus (HIV), Sexually Transmitted Disease (STD) Trial in Philadelphia (STAND HIV Risk Reduction
Completed
- Human Immunodeficiency Virus (HIV)
- Sexually Transmitted Disease (STD)
- STAND HIV Risk Reduction Intervention
- Text Messaging Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 11, 2019
Mitochondria in HIV and Aging (MITO+)
Completed
- Human Immunodeficiency Virus (HIV)
- Mitochondrial Diseases
-
Aurora, ColoradoUniversity of Colorado - Anschutz Medical Campus
Sep 24, 2019